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Summary
Bacteriophages are present in virtually all ecosys-
tems, and bacteria have developed multiple antiphage
strategies to counter their attacks. Clostridium diffi-
cile is an important pathogen causing severe intesti-
nal infections in humans and animals. Here we show
that the conserved cell-surface protein CwpV pro-
vides antiphage protection in C. difficile. This protein,
for which the expression is phase-variable, is classi-
fied into five types, each differing in their repeat-
containing C-terminal domain. When expressed
constitutively from a plasmid or the chromosome of
locked ‘ON’ cells of C. difficile R20291, CwpV con-
ferred antiphage protection. Differences in the level of
phage protection were observed depending on the
phage morphological group, siphophages being the
most sensitive with efficiency of plaquing (EOP)
values of < 5 × 10−7 for phages ϕCD38-2, ϕCD111 and
ϕCD146. Protection against the myophages ϕMMP01
and ϕCD52 was weaker, with EOP values between
9.0 × 10−3 and 1.1 × 10−1. The C-terminal domain of
CwpV carries the antiphage activity and its deletion,
or part of it, significantly reduced the antiphage pro-
tection. CwpV does not affect phage adsorption, but
phage DNA replication is prevented, suggesting a
mechanism reminiscent of superinfection exclusion
systems normally encoded on prophages. CwpV thus
represents a novel ubiquitous host-encoded and
phase-variable antiphage system in C. difficile.
Introduction
With an estimated 1031 particles in the biosphere, bacte-
riophages (phages) outnumber bacteria by a factor of at
least 10. This means phages are present in virtually all
ecosystems (Hatfull, 2008). Bacteria sometimes benefit
from the incorporation into their genome of new prophages
(i.e. integrated phages) that improve their fitness and/or
virulence (Brussow et al., 2004; Fortier and Sekulovic,
2013). Nevertheless, bacteria have evolved multiple strat-
egies to protect themselves from lytic phage attacks
(Labrie et al., 2010).
These strategies aim at hampering various steps of the
infection process, from phage adsorption to DNA injection,
DNA replication and maturation, transcription and transla-
tion [for a review see (Labrie et al., 2010)]. For example,
bacteria can modify or block receptors onto which phages
adsorb to initiate the infection. Restriction-modification
(R-M) systems are also widespread and cleave the incom-
ing phage DNA (Pingoud et al., 2005). Abortive infection
(Abi) systems are mechanisms of ‘innate immunity’
adopted by bacteria to limit phage propagation. This ‘altru-
istic suicide’ strategy aims at protecting the uninfected
surrounding cells and keeping phage populations at a
minimum, but the net result is death of the infected cells
(Chopin et al., 2005). Clustered regularly interspaced short
palindromic sequences (CRISPRs) represent an RNA-
based ‘adaptive immunity’ system protecting cells from
phage infection and from the transfer of foreign DNA
(Barrangou et al., 2007).
Superinfection exclusion (Sie) systems prevent phage
infection by interfering at a very early step in the infection
process. Contrary to other antiphage systems that are
mostly encoded on plasmids or on the chromosome of the
bacterial host, Sie are generally encoded by temperate
phages. When a Sie-encoding phage integrates into the
chromosome of its host to initiate a lysogenic cycle, it
expresses a protein that prevents lytic reinfection (or
superinfection) by the same phage or related phages. The
mode of action of Sie is blocking of phage DNA entry.
Some Sie systems consist in membrane-bound proteins
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that act as molecular decoys to the infection process. For
example, Sie proteins are thought to prevent infecting
phages from bridging with the cytoplasmic membrane
or membrane protein(s) required for DNA injection, by
interacting directly with a phage structural component.
Alternatively, Sie proteins could possibly mask host-
encoded DNA injection proteins, thereby making them
unavailable for phage infection (McGrath et al., 2002).
Several Sie systems have been described in Gram-
negative bacteria, including the Imm and Sp membrane
proteins encoded by coliphage T4, and the Sim and SieA
systems encoded by many prophages from Enterobacte-
riaceae species (Labrie et al., 2010). Imm changes the
conformation of the phage DNA injection site, thereby
preventing DNA entry into the cytoplasm. Sp inhibits the
lysozyme activity located at the tip of the T4 phage tail,
which is required to drill a hole into the peptidoglycan wall
to enable DNA injection (Lu and Henning, 1994).
In Gram-positive bacteria, a few Sie systems have been
identified, mainly in phages of Lactococcus lactis
(McGrath et al., 2002; Mahony et al., 2008) and Strepto-
coccus thermophilus (Sun et al., 2006; Bebeacua et al.,
2013). They are all predicted or have been shown to be
membrane-associated proteins that function by blocking
phage DNA injection. The prototype Sie system in L. lactis
is Sie2009 encoded by the lactococcal phage Tuc2009.
Although Tuc2009 is a member of the P335 phage
species (Jarvis et al., 1991), Sie2009 confers resistance to
a genetically distinct group of lactococcal phages, the 936
(McGrath et al., 2002). Additional genes encoding similar
Sie systems have been identified in multiple lactococcal
strains (McGrath et al., 2002; Mahony et al., 2008). In
S. thermophilus, the temperate phage TP-J34 encodes
Ltp, a 142 amino acid lipoprotein conferring antiphage
activity against similar S. thermophilus phages, but that
also provides strong protection against a completely dis-
tinct group of L. lactis phages, in particular P008 (Mahony
et al., 2006). Analysis of P008 mutants capable of over-
coming the Ltp system revealed mutations in the tail tape
measure protein (TMP). Crystal structure analysis of Ltp
suggests that the antiphage activity results from the inter-
action between Ltp and the phage TMP while it is being
ejected from the tail tube during infection, thereby pre-
venting the formation of a channel through the bacterial
membrane for passage of the viral DNA (Bebeacua et al.,
2013).
Clostridium difficile is the main cause of antibiotic-
associated diarrhea in industrialized countries (Lo Vecchio
and Zacur, 2012). Although many phages infecting C. dif-
ficile have been described (Hargreaves and Clokie, 2014;
Sekulovic et al., 2014), no functional antiphage system has
been functionally characterized in this species so far. Nev-
ertheless, bioinformatics analyses revealed the presence
of putative Abi systems in a few phage genomes, including
AbiF in phage ϕC2 (ORF37) (Goh et al., 2007; Hargreaves
et al., 2014) and an Abi-like protein (CDR20291_1462) in
the phi-027 prophage present in all ribotype 027 isolates,
including the R20291 (Stabler et al., 2009). In addition,
CRISPRs and CRISPR-associated (Cas) proteins are
widely distributed in C. difficile genomes (Hargreaves
et al., 2014), but although the system seems to be func-
tional (Soutourina et al., 2013), an antiphage phenotype
has never been demonstrated experimentally. Likewise,
the CdiCD6I/M.CdiCD6I and CdiCD6II/M.CdiCD6II R-M
systems have been described in C. difficile, but their activ-
ity against phages has never been tested (Purdy et al.,
2002).
CwpV is a conserved cell wall protein present in all
C. difficile isolates and which is the largest member of the
family of cell wall proteins (CWPs). Five different types of
CwpV have been described to date, each differing in its
C-terminal domain. The characteristic feature of this
domain is the presence of 4–9 tandem repeats of amino
acids, each repeat comprising between 79 and 120 amino
acids (Reynolds et al., 2011). CwpV is exported to the cell
surface through a secA2-dependent secretion system
(Fagan and Fairweather, 2011). Once exported, auto-
processing of the protein at a specific cleavage site gen-
erates an N-terminal fragment of ∼ 42 kDa and a
C-terminal fragment of variable size depending on the
CwpV type. The two fragments then re-associate through
non-covalent bonding into a heterodimer to generate the
mature CwpV protein, which is anchored to the cell wall via
three CWB2 cell wall–anchoring domains (Dembek et al.,
2012; Willing et al., 2015). CwpV is a major constituent of
the C. difficile cell wall, representing ∼ 13% of the total
surface layer proteins (Reynolds et al., 2011). The biologi-
cal function of CwpV is still unclear, although CwpV was
shown to promote bacterial aggregation in vitro, suggest-
ing a possible implication in gut colonization (Reynolds
et al., 2011).
One of the characteristic features of CwpV is its phase-
variable expression, which is conserved among all CwpV
types identified (Emerson et al., 2009). Only ∼ 5% of bac-
teria from a culture actively transcribe the cwpV gene. The
site-specific recombinase RecV catalyzes the recombina-
tion of a genetic switch located between the gene and the
promoter, thereby turning ‘ON’ and ‘OFF’ the expression
of cwpV (Emerson et al., 2009).
In this study, we provide experimental evidence showing
that the conserved cell wall protein CwpV from C. difficile
has antiphage activity. We show that cells turning the
expression of cwpV ‘ON’ become resistant to infection by
different phages, including members of the Siphoviridae
and Myoviridae families. Our data strongly support a model
in which CwpV prevents phage DNA from entering the cell,
which is a mechanism reminiscent of superinfection exclu-
sion systems encoded by other temperate phages.
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Results
CwpV protects against phage infection
In a previous transcriptomic study with C. difficile R20291,
we isolated a lysogen carrying the episomal ϕCD38-2
prophage in which the cwpV gene (CDR20291_0440)
was upregulated about 20 fold (Sekulovic and Fortier,
2015). This observation was intriguing, and although it is
still unknown how ϕCD38-2 interferes with cwpV expres-
sion, it raised interesting questions. The cwpV gene
encodes a cell wall protein present in all C. difficile iso-
lates analyzed to date. Although the function of the protein
remains uncertain, experimental evidence suggests that it
participates in bacterial aggregation, which could possibly
contribute to colonization of the gut mucosa (Reynolds
et al., 2011). Of note, cwpV expression is subject to phase
variation, i.e. only a fraction of a bacterial population
expresses the gene (Emerson et al., 2009). The biological
reason for such phase variation is still unknown, and
different hypotheses have been proposed. One of them is
that CwpV could possibly participate in resistance to bac-
teriophage infection (Reynolds et al., 2011). Indeed, a
number of phage receptors and phage resistance
systems are subject to phase variation (Hoskisson and
Smith, 2007; Seed et al., 2012). We therefore sought to
verify if CwpV could protect against phage infection in
C. difficile.
We used the R20291 strain, a ribotype 027 epidemic
isolate that is susceptible to infection by three related
temperate siphophages from our collection: ϕCD38-2,
ϕCD111 and ϕCD146 (Sekulovic et al., 2011; 2014). We
also used the R20291OFF strain, a R20291 mutant in
which cwpV is not expressed (Sekulovic and Fortier,
2015) (Table 1). This mutant was created by inactivating
the recV gene encoding the site-specific recombinase
RecV, using the ClosTron system (Heap et al., 2007;
Reynolds et al., 2011). Inactivation of recV prevents
recombination of the epigenetic switch controlling tran-
scription of cwpV (Emerson et al., 2009), thereby allow-
ing the isolation of clones in which the switch is locked
in the ON or OFF configuration. The absence of cwpV
expression in R20291OFF was confirmed by RT-qPCR,
Western blot and immunofluorescence (Sekulovic and
Fortier, 2015).
We then cloned the R20291 type II cwpV gene (cwpV-II)
on the pRPF144 plasmid (Fagan and Fairweather, 2011),
under the control of the constitutive promoter Pcwp2, leading
to pOS200 (Table 1). This plasmid was transferred by
conjugation into the R20291OFF mutant that does not
express the chromosomal copy of cwpV. The presence of
CwpV-II at the bacterial surface was verified by Western
blot and immunofluorescence on stationary-phase cells
(Figs. S1 and S2). Next, using a spot-test infection assay,
we assessed the impact of the overexpression of cwpV-II
on the susceptibility to infection by ϕCD38-2, ϕCD111 and
ϕCD146. While the R20291OFF strain was fully susceptible
to infection by all three phages, as it is the case for the wild
type strain (Sekulovic et al., 2014) (not shown here), we
observed a complete absence of infection in strain
R20291OFF(cwpV-II) overexpressing cwpV-II (Fig. 1). In
spot-test assays, the relative multiplicity of infection (MOI)
is very high at the point of phage deposition, especially with
high titer dilutions. Therefore, we also assessed the influ-
ence of cwp-II expression on susceptibility to phage infec-
tion in conditions where phages and bacteria were in a ratio
of 1 to 1 (MOI = 1). We performed a cell survival assay in
which we infected C. difficile in broth with ϕCD38-2, fol-
lowed by plating of the infected bacteria. As shown in
Fig. 2, 96.2% ± 18.5% of the R20291OFF(cwpV-II) bacteria
survived the infection, whereas only 13.3% ± 6.8% of the
R20291OFF bacteria survived. As a comparison, we also
infected the parental wild type R20291 strain, and
20.8% ± 2.5% of bacteria survived. These results further
confirmed that overexpression of cwpV-II confers phage
resistance and that the complete absence of CwpV from
the cell surface of the R20291OFF strain increases suscep-
tibility to phage infection.
Because the R20291OFF(cwpV-II) strain overexpresses
cwpV from an unrelated constitutive promoter on a
plasmid, which does not reflect the natural condition, we
constructed a strain in which cwpV was expressed from
its own promoter on the chromosome. This was done by
selecting recV mutants in which the genetic switch con-
trolling the expression of cwpV was locked in the ‘ON’
configuration, i.e. strain R20291ON (Table 1). The consti-
Fig. 1. Susceptibility of C. difficile to phage infection in spot-test
assays. Bacterial lawns were prepared with the wild-type R20291,
or the R20291OFF mutant strain, carrying (+) or not (−) the pOS200
plasmid expressing the cwpV type II. A 5 μl drop containing
different titers of the phages ϕCD38-2, ϕCD111 or ϕCD146 were
then deposited on top of the lawns. Zones of clearing after
incubation denote susceptibility to phage infection. The assay has
been repeated at least three times and a representative result is
shown.
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tutive expression of cwpV in all cells of the R20291ON
strain was confirmed by immunofluorescence (Fig. S1). A
strong protection against ϕCD38-2 infection was observed
in bacterial survival assays performed with the R20291ON
strain, with a survival rate of 76.7% ± 10.8% (Fig. 2). This
suggests that under normal conditions, when an individual
cell expresses cwpV-II, phage infection is inhibited effi-
ciently in that cell.
The presence of surviving R20291OFF cells after phage
exposure suggested that some cells were not infected, or
some of them became lysogenic. Once a lysogen is
formed, it becomes resistant to further killing by the same
phage. We used an MOI of 1 in our survival assay to
minimize lysogeny, which is promoted at higher MOI
(Oppenheim et al., 2005). However, at an MOI of 1, we
expected that some cells were not infected, and we could
not rule out the possibility that lysogens also formed
during the process. We therefore determined the propor-
tion of lysogens among surviving cells following infection
with ϕCD38-2. We randomly picked 30 colonies from each
infection experiment and analyzed them by PCR for the
presence of ϕCD38-2 using specific primers (LCF 312 and
LCF 313; Table S1). No lysogens could be detected in
R20291OFF(cwpV-II), but 3/30 (10%) of survivors from
R20291 and 6/30 (20%) from R20291OFF were positive for
ϕCD38-2, confirming that lysogens were formed during
Table 1. List of bacterial strains, plasmids and phages used in this study.
Strain, plasmid or phage Characteristic or description Reference or source
C. difficile
R20291 Epidemic isolate, ribotype 027 Stabler et al. (2006)
R20291OFF R20291 Cd1004-144a::CT, recV mutant, cwpV genetic switch OFF Sekulovic and Fortier (2015)
R20291OFFlysogen R20291OFF strain, carrying the ϕCD38-2 prophage This study
R20291ON R20291 Cd1004-144a::CT, recV mutant, cwpV genetic switch ON This study
R20291ONlysogen R20291ON strain, carrying the ϕCD38-2 prophage This study
R20291OFF(cwpV-I) R20291OFF containing pCBR080, cwpV-I full length This study
R20291OFF(cwpV-III) R20291OFF containing pCBR106, cwpV-III full length This study
R20291OFF(cwpV-IV) R20291OFF containing pCBR107, cwpV-IV full length This study
R20291OFF(cwpV-V) R20291OFF containing pCBR109, cwpV-V full length This study
R20291OFF(cwpV-II) R20291OFF containing pOS200, cwpV-II full length This study
R20291OFF(cwpV-II N-term) R20291OFF containing pOS201, cwpV-II N-term fragment This study
R20291OFF(cwpV-II 3reps) R20291OFF containing pOS202, cwpV-II 3 repeats This study
R20291OFF(cwpV-II ΔSigP ) R20291OFF containing pOS203, cwpV-II ΔSignalP This study
CD384 Human isolate Sirard et al. (2011)
CD384(pRPF144E) CD384 containing pRPF144E This study
CD384(cwpV-I) CD384 containing pCBR080, cwpV-I full length This study
CD384(cwpV-III) CD384 containing pCBR106, cwpV-III full length This study
CD384(cwpV-V) CD384 containing pCBR109, cwpV-V full length This study
Escherichia coli
CA434 HB101 carrying plasmid R702 Purdy et al. (2002)
Phage
ϕCD38-2 Siphoviridae Sekulovic et al. (2011)
ϕCD111 Siphoviridae Sekulovic et al. (2014)
ϕCD146 Siphoviridae Sekulovic et al. (2014)
ϕMMP01 Myoviridae Meessen-Pinard et al. (2012)
ϕCD52 Myoviridae Fortier and Moineau (2007)
Plasmid
pRPF144 Pcwp2-gusA cassette from pRPF137 subcloned into pMTL960 Fagan and Fairweather (2011)
pRPF144E pRPF144 without gusA and with a unique BamHI site This study
pCBR080 pMTL960 containing the full-length cwpV-I gene from strain 630 with
C-terminal streptavidin-tag
Reynolds et al. (2011)
pCBR106 pMTL960 containing the full-length cwpV-III gene from strain CDKK167 with
C-terminal streptavidin-tag
Reynolds et al. (2011)
pCBR107 pMTL960 containing the full-length cwpV-IV gene from strain M9 with
C-terminal streptavidin-tag
Reynolds et al. (2011)
pCBR109 pMTL960 containing the full-length cwpV-V gene from strain AY1 with
C-terminal streptavidin-tag
Reynolds et al. (2011)
pOS200 pRPF144 containing the full-length cwpV-II gene from strain R20291 This study
pOS201 pRPF144 containing the N-terminal domain of the cwpV-II gene from strain
R20291
This study
pOS202 pRPF144 containing the N-terminal domain + 3 proximal repeats of the
cwpV-II gene from strain R20291
This study
pOS203 pRPF144 containing the cwpV-II gene with deleted signal peptide from strain
R20291
This study
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the assay. However, most of the non-lysogenic colonies
were likely non-infected cells. It is also noteworthy to
mention that no lysogens could be detected following
infection of the R20291ON strain.
CwpV protects against Siphoviridae phage infection
The CwpV protein is found in all C. difficile isolates ana-
lyzed to date, and it has been further classified into five
different types according to the number and sequence of
amino acid repeats composing the variable C-terminal
region (Reynolds et al., 2011) (Fig. 3). In order to verify if
the antiphage activity observed with the type II CwpV could
be extended to other types, we transferred into the
R20291OFF strain plasmids carrying one of the other known
types, i.e. cwpV type I, III, IV and V (Table 1). By incorpo-
rating into soft agar overlays (Fortier and Moineau, 2009)
dilutions of a phage lysate from ϕCD38-2, ϕCD111 or
ϕCD146 (up to 5 × 107 pfu), we were able to calculate their
efficiency of plaquing (EOP) on the different strains, i.e. the
proportion of phages that can infect a given strain, com-
pared with a reference strain, in this case wild-type
R20291.As shown in Table 2, we confirmed that all types of
CwpV successfully blocked infection by the three
siphophages, with EOP values below the maximum phage
input used in the assay (i.e. EOP < 5 × 10−7) (Table 2). In
fact, no phage plaques could be detected with ϕCD38-2,
Fig. 2. Bacterial survival following infection with phage ϕCD38-2.
Bacteria were infected with phage ϕCD38-2 at a MOI of 1, and
were subsequently plated after 15 minutes of incubation. The
R20291ON (locked ‘ON’) and R20291OFF (locked ‘OFF’) strains were
compared with the wild-type R20291. Plasmids carrying either the
full-length cwpV-II (pOS200), a truncated version with only the
N-terminal portion (pOS201) or a partially truncated version lacking
the distal 5 repeats (pOS202) were also tested in R20291OFF.
Colonies representing bacteria that survived the infection were
counted and the result is expressed as a percentage of the ratio
between infected and uninfected controls. Vertical bars represent
means ± standard deviation (SD) of three independent biological
replicates, which were each plated in technical triplicates. One-way
ANOVA comparisons were done with R20291OFF as the reference
condition (**P < 0.01; ****P < 0.0001).
Fig. 3. Schematic representation of the CwpV constructions used in this study. The type of CwpV is indicated on the left, along with the
strain from which it originates, and the plasmid carrying a copy of the corresponding gene used for expression assays in R20291OFF. Color
code: Black, signal peptide; gray, cell wall-anchoring domain (PF04122); white, unknown function; pink, serine/glycine-rich region; blue, type I
repeats; orange, type II repeats; green, type III repeats; red, type IV repeats, purple, type V repeats. Color shades represent different
sequence variants of a repeat type. Constructions marked with asterisks are not naturally occurring. Modified from (Reynolds et al., 2011).
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ϕCD111 or ϕCD146, confirming that all five types of
CwpV provided strong antiphage activity against these
siphophages.
Next, we wanted to determine if CwpV could also
protect C. difficile against other morphologically unrelated
phages, for example members of the Myoviridae family,
i.e. phages with non-flexible contractile tails (Ackermann
and Prangishvili, 2012). One limitation that we faced was
that only Siphoviridae phages from our collection could
infect the R20291 strain. To address this, we selected
another C. difficile strain that was susceptible to infection
by myophages and into which conjugation was possible,
CD384 (Sekulovic et al., 2014). We had two different
myophages that could replicate efficiently on this strain,
ϕMMP01 (Meessen-Pinard et al., 2012) and ϕCD52
(Fortier and Moineau, 2007). We transferred by conjuga-
tion the plasmids carrying the different types of cpwV into
CD384. Unfortunately, despite several attempts the plas-
mids carrying type II and type IV cwpV could not be
transferred. EOP assays with ϕMMP01 and ϕCD52
revealed that CwpV type I was the most effective at pre-
venting infection, especially against ϕMMP01 with an
EOP of 9 × 10−3, and that type V was the least effective,
with an EOP of 1.1 × 10−1 with phage ϕCD52 (Table 2).
Overall, CwpV seemed to provide some protection
against infection by myophages, but the EOP values were
at least 3 to 4-log higher suggesting that CwpV is less
effective against this phage family. Taken all together, our
results suggest that the antiphage activity provided by all
five types of CwpV is stronger with siphophages.
The C-terminal domain of CwpV carries the
antiphage activity
As the N-terminal domain of CwpV is involved in cell wall
attachment (Willing et al., 2015), we hypothesized that the
antiphage property was provided by the C-terminal
domain carrying the amino acid repeats. In order to verify
this, we constructed two deletion mutants of the CwpV
type II protein from R20291. The first plasmid, pOS201,
encoded a CwpV-II lacking the entire C-terminal domain,
and only the N-terminal domain required for cell wall
anchoring was retained (Reynolds et al., 2011; Dembek
et al., 2012) (Fig. 3). The second plasmid, pOS202,
lacked the five distal amino acid repeats and retained only
the first three proximal repeats within the N-terminal
domain. Both plasmids were transferred by conjugation
into R20291OFF and the presence of the protein at the cell
surface was verified by immunofluorescence and western
blot (Figs S1 and S2). Then, we performed bacterial sur-
vival assays to assess the susceptibility to phage infec-
tion. The pOS201 plasmid lacking the whole C-terminal
domain did not efficiently protect against ϕCD38-2 infec-
tion, with a survival rate of 33.07% ± 0.72%, which was
not significantly different from the rate observed with wild-
type R20291 (20.8% ± 2.5%; Fig. 2). With the pOS202
plasmid encoding a partially deleted CwpV, the protection
was intermediate, with a survival rate of 52.07% ± 5.90.
These results suggest that the C-terminal repeats are
indeed responsible for the antiphage activity of CwpV.
CwpV functions as a superinfection exclusion
(Sie) system
The spot-test and EOP experiments suggest that when
cwpV is expressed, no progeny phages are generated (no
plaques and no lysis), but the infection process could be
abrogated at many different steps. Considering the loca-
tion of CwpV at the cell surface, the first obvious hypothesis
was that CwpV blocked phage adsorption, thus cutting
short the whole infection process at the very early steps. To
test this, we performed phage adsorption assays with
C. difficile strains expressing either the full-length cwpV-II
gene from a plasmid [R20291OFF(cwpV-II], or from the
chromosome (R20291ON). We also compared adsorption
with a strain that does not express cwpV at all (R20291OFF).
As shown in Fig. 4, results with wild-type R20291 and the
R20291OFF strains were almost identical, with adsorption
Table 2. Efficiency of plaquing (EOP) for morphologically different phages infecting strains expressing various types of CwpV.
CwpV
type
Siphoviridae Myoviridae
ϕCD38-2 ϕCD111 ϕCD146 ϕMMP01 ϕCD52
I < 5 × 10−7 < 5 × 10−7 < 5 × 10−7 9 × 10−3 1.5 × 10−2
II < 5 × 10−7 < 5 × 10−7 < 5 × 10−7 ND ND
III < 5 × 10−7 < 5 × 10−7 < 5 × 10−7 5.6 × 10−2 3.3 × 10−2
IV < 5 × 10−7 < 5 × 10−7 < 5 × 10−7 ND ND
V < 5 × 10−7 < 5 × 10−7 < 5 × 10−7 9.7 × 10−2 1.1 × 10−1
ND = not determined.
CwpV is a cell wall–associated protein conserved across the Clostridium difficile species. An epigenetic switch controls the expression of the cwpV
gene in a phase-variable manner. Bacterial cells that are in the « ON » state express cwpV and become resistant to phage infection through
blocking of phage DNA injection, in a manner reminiscent of superinfection exclusion systems. CwpV thus represents a novel antiphage system
conserved in C. difficile.
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rates of 98.7% ± 0.5 and 98.0% ± 0.5 respectively. The
adsorption on R20291ON and R20291OFF(cwpV-II) was
similar but slightly lower, with rates of 92.9% ± 2.2 and
92.8% ± 1.4 respectively. Although the difference in phage
adsorption between R20291OFF and R20291OFF(cwpV-II)
was statistically significant (p = 0.014), it cannot explain
the difference seen in phage infection and the high level of
protection observed in spot-test, EOP and bacterial sur-
vival assays. We also performed adsorption tests with
phages ϕCD52 and ϕMMP01 on CD384 carrying the empty
plasmid pRPF144E, as well as strain CD384 expressing
cwpV-I, cwpV-III or cwpV-V. In all cases, adsorption was
not significantly affected upon overexpression of cwpV
(Fig. S3). Altogether, we conclude that the antiphage activ-
ity does not result from a defect in phage adsorption but
that a step downstream in the infection process is likely
affected.
A logical hypothesis would be that CwpV blocks phage
DNA injection, as the protein is located at the cell surface.
To verify this, we performed time-course phage infection
assays during which ϕCD38-2 genomic DNA replication
was monitored by Southern blotting in the absence
(R20291OFF) or presence [R20291OFF(cwpV-II)] of the full-
length cwpV-II gene (Fig. 5). Replication of phage DNA
was readily detected after 20 min post-infection in
R20291OFF and reached its maximum intensity after
60–90 minutes, which is in agreement with our previous
Fig. 4. Phage adsorption assay of ϕCD38-2 on strains expressing
or not the type II CwpV. Phages were allowed to adsorb for
30 minute, and then bacteria were pelleted. The adsorption rate is
expressed as a percentage of the ratio between non-adsorbed
phages in the supernatant compared to the initial phage inoculum.
Vertical bars represent means ± SD of three independent biological
replicates, which were also plated in technical triplicates. One-way
ANOVA comparisons were done with R20291OFF as the reference
strain (*P < 0.05).
Fig. 5. Phage DNA replication assay. The
R20291OFF and R20291OFF strain carrying the
pOS200 plasmid enabling overexpression of
the type II CwpV were each infected with
ϕCD38-2 at a MOI of 1. Samples of the
infected cultures were collected at different
time points post-infection, and whole bacterial
genomic DNA was extracted. DNA was
digested with HindIII and analysed by agarose
gel and ethidium bromide staining (upper
panel). Southern blot hybridization using a
Dig-labeled whole phage DNA probe was
then performed to detect phage DNA
replication (lower panel). A non-infected (NI)
control was run in parallel, along with a
positive control consisting in the purified
ϕCD38-2 DNA.
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data on the phage lytic cycle (Sekulovic et al., 2011). On
the other hand, no phage DNA replication could be
detected at any time point in R20291OFF(cwpV-II) express-
ing cwpV even after 90 minutes. This result strongly sug-
gests that phage DNA does not enter bacterial cells when
CwpV is present at the cell surface. Yet, we could not rule
out the possibility that phage DNA was injected, but that
intracellular CwpV in transition to the cell surface quickly
inhibited phage replication. To address this, we con-
structed pOS203, a plasmid encoding a CwpV mutant
lacking only the signal peptide, to prevent its translocation
to the cell surface (Fig. 3). The pOS203 plasmid
was transferred into the R20291OFF strain (yielding
R20291OFF(cwpV-II ΔSigP) to avoid contribution from the
chromosomal copy of cwpV. The absence of CwpV from
the cell surface was confirmed by immunofluorescence on
intact cells (Fig. S1) and by analyzing S-layer extracts by
SDS-PAGE and Western blot (Fig. S2). As expected,
CwpV was detected in the cytoplasmic fraction, confirm-
ing that the protein was expressed (Fig. S2). Strain
R20291OFF(cwpV-II ΔSigP) proved to be fully susceptible
to infection with phage ϕCD38-2, with an EOP value of
∼ 1. Therefore, the presence of intracellular CwpV-II does
not interfere with phage DNA replication and the infection
proceeds normally. As an additional control experiment,
we inactivated the recV gene in a strain already carrying
ϕCD38-2, and selected R20291 lysogens with an intact
cwpV gene under the control of a switch in the ON or OFF
configuration. We then monitored prophage induction,
with or without mitomycin C treatment and did not observe
significant differences in the number of phage particles
released (Table S1). Taken together, our results show that
CwpV does not interfere with viral DNA replication or early
gene transcription when the prophage is already inside
the cells. However, CwpV blocks phage DNA injection
because phage DNA replication is not detected when
exogenous phage particles are used to infect cwpV-
expressing cells. Therefore, our data strongly suggest that
CwpV functions in a way similar to superinfection exclu-
sion (Sie) systems, although it is not encoded by a
prophage.
Discussion
In this study, we provide experimental evidence showing
that the cell wall protein CwpV protects C. difficile from
phage infection. We show that all five types of CwpV
protect against siphophages, whereas types I, III and V
protect against infection by myophages, although less
efficiently. The C-terminal, repeat-containing region of
CwpV carries the antiphage activity. Our data further show
that phage particles are able to adsorb to their host, but the
absence of phage DNA replication suggests that the inhi-
bition occurs at the step of DNA injection. Such antiphage
phenotype is reminiscent of the Sie family of proteins,
which are generally membrane-associated prophage-
encoded proteins (McGrath et al., 2002; Mahony et al.,
2008; Labrie et al., 2010). CwpV thus represents a novel
host-encoded cell wall–associated and phase-variable
Sie-like antiphage system ubiquitous within the C. difficile
species.
Constitutive expression of any type of CwpV from a
plasmid was sufficient to completely block infection by
three related phages from the Siphoviridae family.
However, in the R20291ON strain in which cwpV is
expressed constitutively from its own promoter, protection
was somewhat reduced in survival assays with ∼ 75%
survival. In addition, EOP values of only 0.5 to 10−1 were
observed with the R20291ON strain (data not shown), sug-
gesting that the phage-to-host ratio is critical for optimal
protection. According to a previous study, the amount of
CwpV in ‘ON’ cells represents 13.3% of the total surface
proteins (Reynolds et al., 2011). The major cell wall protein
is SlpA that forms a two-dimensional array into which
CwpV is likely inserted. Hence, areas or zones of the cell
surface may be devoid of CwpV, which would explain why
at high MOI, phages successfully infect the cell. The accu-
mulation of CwpV at the cell surface is greater when
expression occurs from a multicopy plasmid. In agreement
with this, our qRT-PCR analyses showed 6.25-fold more
expression in R20291OFF(cwpV-II) compared with the
R20291ON. Likewise, SLP extractions also showed larger
amounts of CwpV in extracts from cells expressing the
gene from a plasmid compared with locked-ON cells
(Fig. S2). It is also possible that a certain amount of CwpV
must be present at the surface to reach a stoichiometric
threshold with a bacterial component participating in phage
infection. For example, the number of copies of the outer
membrane porin OmpC used as a phage receptor by
phage T4 is estimated at around 102 to 103 per Escherichia
coli K-12 cell (Lu et al., 1993). A similar dose-dependent
response has been reported with other antiphage systems
such as those from lactic acid bacteria, whereby transfer-
ring the antiphage gene onto a high copy plasmid leads to
a stronger antiphage phenotype (Bouchard et al., 2002;
McGrath et al., 2002; Sun et al., 2006). C. difficile cells that
turn ‘ON’ the expression of cwpV probably produce enough
of the protein to acquire significant protection against
phage infection in an in vivo context, where the MOI for a
specific phage is probably low compared with in vitro
conditions.
We showed that CwpV has a very strong antiphage
activity toward all three siphophages tested (ϕCD38-2,
ϕCD111 and ϕCD146), whereas it has only modest activity
against myophages (ϕMMP01 and ϕCD52). Of note, the
three siphophages used are very similar genetically and
morphologically, yet they have slightly different host
spectra (Sekulovic et al., 2014). On the other hand, the
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ϕMMP01 and ϕCD52 myophages are different from the
siphophages, both genetically and morphologically, and
they also have distinct host spectra (Sekulovic et al.,
2014). The fact that CwpV is active against both phage
families suggests that it interferes with a phage structure,
host component, or at a step of the infection process
common to both groups. One possibility is that both types
of phages use different strategies to dock at the mem-
brane interface to inject their DNA and that CwpV inter-
feres less efficiently in the case of the Myoviridae phages.
Knowledge on the biology and molecular structure of
C. difficile phages is very limited so it is hard to tell which
features of the siphophages and myophages CwpV could
target. Likewise, the bacterial receptor(s) recognized by
these phages to infect their host is (are) unknown. Such
receptor could be a surface carbohydrate, a membrane
protein or another surface component (Chapot-Chartier,
2014). However, adsorption of both Siphoviridae and
Myoviridae phages is not prevented in cells expressing
cwpV, suggesting that CwpV does not block a phage
receptor. Moreover, as we did not detect phage DNA
replication inside infected cells, the most logical hypoth-
esis is that CwpV interferes with phage DNA injection.
This is further supported by the fact that the infection
process was not altered in cells expressing a cwpV
mutant lacking the signal peptide required to export CwpV
to the cell surface and that induction and replication of the
ϕCD38-2 prophage was normal in a lysogenic host
expressing cwpV. In summary, the interference is likely
occurring at the cell surface or membrane interface with
the fully processed CwpV. Deleting part or all of the
C-terminal amino acid repeats affected the antiphage
activity proportionally, suggesting that the number of
repeats rather than their sequence is crucial for CwpV-
mediated antiphage activity.
One of our hypotheses is that CwpV interacts with a
structural component of the phage tail, which would be
conserved between similar siphophages and that would be
sufficiently different or less accessible in myophages.
Alternatively, Myoviridae and Siphoviridae phages might
use different host factors and/or mechanisms to inject their
DNA, which might involve different types of interactions
with the cell membrane and at which point CwpV might
interfere. Both Myoviridae and Siphoviridae phages are
part of the order Caudovirales, which includes all tailed
phages, and it is not uncommon to find phages with iden-
tical morphologies, but which are completely different
genetically. The structure of phage tails is thus highly
conserved, but a main distinction between siphophages
and myophages is the presence of a contractile tail sheath
surrounding the tail tube of the latter (Fokine and
Rossmann, 2014).
Because there is no sequence homology between the
siphophages and myophages used in our study, it is
hard to tell which phage structural component(s) CwpV
could target. One hypothesis is that CwpV interacts with
components conserved between the two families and
that are less accessible in myophages. The absence of
a tail sheath in siphophages leaves the tail tube entirely
exposed and might serve as a potential target for CwpV.
In myophages such as the coliphage T4, the tail tube
becomes exposed only after tail sheath contraction,
which is triggered by interactions of phage tail fibers with
bacterial host receptors (Leiman et al., 2003). In the
siphophage λ, the tail tube protein gpV harbors an
Ig-like domain 2 (Big_2) in its C-terminal region, which
protrudes outside of the tail tube, and which was shown
to be required for optimal host adsorption and infectivity
(Pell et al., 2010). The importance of the tail tube and
TMP in resistance to superinfection exclusion activity
was recently evidenced with coliphages HK97 and
HK022 (Cumby et al., 2012). HK97 encodes gp15, a
membrane protein with superinfection exclusion activity.
Although HK97 and HK022 share extensive sequence
homology in their capsid and tail tip proteins, HK022 is
not susceptible to the action of gp15. However, a HK97/
022 hybrid phage in which a genomic region encoding
the tail tube and TMP from HK97 has been replaced
with that of HK022 is no longer inhibited by gp15. There-
fore, gp15 from HK97 prevents phage DNA entry
through interaction with the phage tail tube or TMP
(Cumby et al., 2012).
In Gram-positive bacteria, only a few examples of Sie
systems have been described, including the 142 amino
acids lipoprotein Ltp encoded by the S. thermophilus
phage TP-J34 (Sun et al., 2006). Most phages infecting
S. thermophilus are related to the lactococcal BK5-T-like
phages, and Ltp from TP-J34 confers protection against
streptococcal phages (EOP of about 10−2) (Sun et al.,
2006). Surprisingly though, it provides stronger protection
against some 936 phages infecting L. lactis, in particular
phage P008, with an EOP < 10−9 (Bebeacua et al., 2013).
This highlights the potentially wide spectrum of some Sie
systems. In a recent study, the crystal structure of the Ltp
protein was reported (Bebeacua et al., 2013) and mutants
of phage P008 capable of bypassing the Ltp antiphage
activity were also isolated. Genome sequencing revealed
specific mutations in the gene encoding the TMP, sug-
gesting that Ltp targets this specific protein. However,
there is no direct experimental evidence of the interaction
between Ltp and TMP (Bebeacua et al., 2013). In
myophages, exposure of the tail tube and TMP is physi-
cally and temporally limited contrary to siphophages
(Leiman et al., 2003). Hence, it is tempting to speculate
that CwpV interacts with the tail tube protein or the TMP,
which would explain why myophages are less sensitive to
the antiphage activity of CwpV. The polymeric and helical
nature of the tail tube and TMP (Leiman et al., 2003;
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Plisson et al., 2007) could possibly allow for interaction
with the repetitive nature of CwpV. In agreement with this,
a partially truncated version of CwpV in which five of the
distal C-terminal repeats have been deleted has a
reduced antiphage activity against siphophages, whereas
complete removal of the C-terminal repeats cause a com-
plete loss of activity. Despite the use of high phage titers
(up to 5 × 109 pfu), we did not detect phage plaques upon
infection of a C. difficile strain overexpressing cwpV,
showing that the CwpV antiphage system is very efficient
under these conditions. As a result, we were unable to
isolate phage mutants capable of overcoming the
antiphage activity of CwpV, which could have given us
hints about the possible phage target.
Our study was limited by a number of technical
hurdles, mainly the availability of a C. difficile strain
equally susceptible to infection by both siphophages and
myophages and that could be genetically manipulated to
reintroduce various cwpV genes. Indeed, phages infect-
ing C. difficile generally have narrow host spectra (Sell
et al., 1983; Mahony et al., 1985; 1991; Dei, 1989; Goh
et al., 2005; Sekulovic et al., 2014), and isolates that are
fully susceptible to siphophages are not, or only partially
susceptible to infection by myophages and vice versa
(Sekulovic et al., 2011; 2014; Meessen-Pinard et al.,
2012). In addition, the availability of Siphoviridae phages
to test against CwpV was limited, with only five
siphophages described so far (Horgan et al., 2010;
Sekulovic et al., 2011; Hargreaves and Clokie, 2014),
three of them being similar (ϕCD38-2, ϕCD111 and
ϕCD146) and another one lacking a propagating host
(ϕCD24-1; our unpublished data).
Concluding remarks
Phase variation in the bacterial world has often been
associated with immune evasion during pathogenic infec-
tions. But in fact, phase variation might serve multiple
other functions associated with virulence, persistence
and colonization (Li et al., 2002; Kearns and Losick,
2005; van der Woude, 2006; Tauseef et al., 2013; Alamro
et al., 2014). For example, phase-variable antiphage
systems can protect subpopulations from lytic phage
attacks (van der Woude, 2006; Hoskisson and Smith,
2007), without compromising the capacity of the whole
bacterial population to acquire new genetic material by
horizontal transfer (Brussow et al., 2004; Fortier and
Sekulovic, 2013). The expression of a phase-variable
antiphage system such as CwpV thus becomes highly
relevant in a context where multiple phage marauders are
present in the mammalian gut (Mills Susan et al., 2013).
Further investigations will be required to determine the
importance of CwpV in antiphage protection during gut
colonization in vivo.
Experimental procedures
Bacterial strains, bacteriophages and plasmids
A complete list of bacterial strains, plasmids and bacterio-
phages used in this study is presented in Table 1. C. difficile
was routinely grown inside an anaerobic chamber (Coy Labo-
ratories), under anaerobic atmosphere (10% H2, 5% CO2 and
85% N2) at 37°C in pre-reduced brain hearth infusion (BHI)
broth or TY broth (3% tryptose, 2% yeast extract, pH 7.4).
Thiamphenicol (15 μg ml−1) and norfloxacin (12 μg ml) were
added when necessary. E. coli was grown aerobically in
Luria–Bertani broth in a shaking incubator at 37°C with
appropriate antibiotics (chloramphenicol 25 μg ml−1 or kana-
mycin 50 μg ml−1) when necessary. Concentrated phage
lysates (≥ 109 pfu ml−1) were prepared by standard phage
induction and amplification protocols as described elsewhere
(Sekulovic et al., 2011) and stored at 4°C.
Determination of phage titers and efficiency of
plaquing (EOP)
For determination of phage titers, we used a standard soft
agar overlay method (Fortier and Moineau, 2009) with 0.5 ml
of a log-phase sensitive strain and 10 mM CaCl2 + 0.4M
MgCl2. For rapid evaluation of bacterial sensitivity to phage
infection, 5 μl of serially diluted phage lysates were spotted
directly on top of the soft agar overlay. Clear zones of lysis in
the bacterial lawn were indicative of a productive phage infec-
tion. The EOP was used for quantitative analysis of bacterial
sensitivity to phage infection and consisted in dividing the
phage titer (in plaque forming units (pfu) ml−1) of a given
phage on the test strain, by the phage titer (in pfu ml−1) of that
phage on a sensitive reference strain (Fortier et al., 2005).
Isolation of R20291OFF and R20291ON clones
Inactivation of the bacterial recombinase RecV from strain
R20291 (CDR20291_1004) using the ClosTron system has
been described previously (Reynolds et al., 2011; Sekulovic
and Fortier, 2015). Colony PCR on putative recV mutants
was performed in order to identify clones for which the
genetic switch controlling the expression of the cwpV gene
(Emerson et al., 2009) was locked either in the ‘ON’ (primer
pair LCF 801 + LCF 714) or ‘OFF’ (primer pair
LCF 796 + LCF 797) configuration (Table S1). To create lyso-
gens with the ‘ON’ or ‘OFF’ configuration, the ϕCD38-2
prophage was introduced first into strain R20291 to create a
lysogen, and then a plasmid carrying the ClosTron construc-
tion was introduced by conjugation to inactivate the recV
gene. As both ‘ON’ and ‘OFF’ configurations exist in a lyso-
genic population, we screened colonies to isolate an
R20291ONlysogen and R20291OFFlysogen. Surface protein
extracts from positive clones were analyzed on polyacryla-
mide gel electrophoresis (SDS-PAGE) followed by Coomas-
sie blue staining to validate the presence (‘ON’ clones) or the
absence (‘OFF’ clones) of CwpV protein at the cell surface.
Cloning and expression of CwpV-related constructions
The full-length cwpV-II gene including the putative ribosome-
binding site was amplified by PCR from C. difficile R20291
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using primers LCF 756 and LCF 757. Truncated versions of
the cwpV-II gene were also amplified by PCR as follows:
primers LCF756 and LCF896 were used to amplify the region
encoding the N-terminal domain of CwpV-II, whereas primers
LCF 756 and LCF 897 were used to amplify the region span-
ning the N-terminal domain + 3 proximal amino acid repeats.
The PCR products were cloned in place of the gusA gene
downstream of the constitutive Pcwp2 promoter in the
pRPF144 plasmid (Fagan and Fairweather, 2011) (Table 1)
using SacI and BamHI restriction enzymes. The resulting
plasmids were named pOS200, pOS201 and pOS202
respectively. An in-frame deletion of the signal peptide from
CwpV was also constructed as follows. The signal peptide
was identified using SignalP 4.1 (http://www.cbs.dtu.dk/
services/SignalP/) (Petersen et al., 2011), and further verified
manually based on conserved characteristics for Gram-
positive species (von Heijne and Abrahmsén, 1989; van
Roosmalen et al., 2004). Next, the 5′ fragment of the cwpV
gene including the ribosome binding site and ATG start codon
was PCR-amplified with primers LCF 941 and LCF 942. A 3′
fragment downstream of the signal peptide and including the
N-terminal cell wall binding domain, C-terminal repeats and a
putative transcriptional terminator was PCR-amplified with
primers LCF 943 and LCF 944. A Gibson isothermal assem-
bly procedure (Gibson et al., 2009) was then used to clone
the two PCR fragments into a modified pRPF144 backbone.
Briefly, the pRPF144 plasmid was digested with SacI and
BamHI to remove the gusA gene. The remaining plasmid
fragment was then treated with T4 DNA polymerase (NEB) to
generate blunt ends, and ligated with T4 DNA ligase (NEB) to
give pRPF144E. The plasmid was linearized with BamHI and
purified by EZ-10 spin column DNA cleanup kit (BioBasic).
Equimolar ratios of 5′ and 3′ cwpV fragments and linearized
pRPF144E were pooled in a total volume of 5 μl and mixed
with 15 μl of Gibson enzyme–reagent master mix containing
5% PEG-8000, 100 mM Tris–HCl pH 7.5, 10 mM MgCl2,
10 mM DTT, 200 nM each of the four dNTPs, 1 mM NAD,
0.08 U T5 exo (Epicentre), 80 U Taq ligase and 0.5 U
Phusion polymerase (NEB). The reaction mix was incubated
at 50°C for 1 h, and 1 μl was used to transform E. coli CA434
competent cells using standard procedures (Sambrook and
Russell, 2001). Positive clones carrying the correct con-
structs were verified by DNA sequencing and subsequently
transferred by conjugation into C. difficile R20291OFF as
described previously (Sekulovic and Fortier, 2015).
Immunoblotting for detection of CwpV
Expression of the recombinant proteins was confirmed by
Western immunoblotting. Briefly, C. difficile cell surface pro-
teins were glycine-extracted as previously described
(Sekulovic and Fortier, 2015). Following S-layer extraction,
cells were washed in 1× PBS and then mechanically lysed
using 0.5 g of acid-washed glass beads (106 μm, Sigma) in a
FastPrep apparatus (MP Bioscience) for 45 second at 4 m s−1.
Proteins were separated by 10% SDS-PAGE and then trans-
ferred on nitrocellulose membranes using standard proce-
dures (Sambrook and Russell, 2001). Immunoblotting was
performed either with chicken IgY primary antibodies specific
to the N-terminal part of CwpV protein (Cat. No.ABIN2039021;
Immune Biosolutions, Sherbrooke, QC) or rabbit primary anti-
bodies raised against the first two C-terminal repeats
(Reynolds et al., 2011). Primary antibodies were detected
using either an HRP-conjugated goat anti-rabbit secondary
antibody (Life Technologies) or an HRP-conjugated alpaga
anti-chicken secondary antibody (Immune Biosolutions) fol-
lowing manufacturers’ recommendations.
Bacterial survival assays
Bacterial survival assays were performed as follows. C. diffi-
cile overnight cultures were used to inoculate 5 ml of fresh TY
broth and bacteria were grown until exponential phase
(OD600nm = 0.5). Then, 0.9 ml of the culture was taken and
mixed with ϕCD38-2 phage lysate in order to obtain a MOI of
1. MgCl2 and CaCl2 were added to a final concentration of
10 mM each, and the volume was completed to 1 ml with
sterile TY broth. An uninfected control without phage was run
in parallel. Both samples were mixed by inversion and incu-
bated for 15 minutes at 37°C, after which aliquots were
quickly diluted in triplicate in 96 well plates. Then, 0.1 ml of
these dilutions was plated on BHI agar and incubated over-
night. The next day, colonies were counted, and the ratio
between infected and uninfected controls was indicative of
bacterial sensitivity to phage infection and expressed as per-
centage of survival ([infected/uninfected] × 100).
Phage adsorption assays
Phage adsorption assays were performed as previously
described with slight modifications (Hyman and Abedon,
2009). Briefly, bacteria from an overnight culture were inocu-
lated in TY broth and grown until exponential phase
(OD600nm = 0.5). Then, 0.9 ml of cells was mixed with 1 × 104
pfu in the presence of salts (10 mM CaCl2 and MgCl2), and
the volume was completed to 1 ml with fresh TY broth.
Phages were allowed to adsorb for 30 minutes at 37°C after
which cells were collected by centrifugation. Free phages in
the supernatant that did not adsorb were counted on stand-
ard soft agar overlays and titers were compared with the
initial phage inoculum. The percentage of adsorption was
calculated with the following formula: 100 – ([residual titer/
initial titer] × 100).
Detection of phage DNA replication
Phage DNA replication within bacterial cells was monitored
as previously described with modifications (Domingues et al.,
2004). Briefly, bacteria from an overnight culture were inocu-
lated in 100 ml of fresh TY broth and allowed to grow until
exponential phase (OD600nm = 0.5) at which point CaCl2 and
MgCl2 were added directly to the culture at final concentra-
tions of 10 mM each. One 5 ml aliquot was immediately taken
as a non-infected control. Then, the phage lysate was added
at a MOI of 1 and 5 ml aliquots were taken at 0, 20, 40, 60 and
90 minutes. Each sample was mixed with an equal amount of
cold acetone-ethanol mix (1:1) in order to stop the replication
machinery in the cell and stabilize the DNA. Cells were har-
vested by centrifugation, washed in 1× PBS and total DNA
was extracted by phenol-chloroform extraction followed by
ethanol precipitation. Two micrograms of total DNA was
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digested with HindIII (NEB) following manufacturer’s instruc-
tions and run through a 0.8% agarose gel. DNA transfer and
Southern hybridization with whole-phage digoxigenin (DIG)-
labeled probe were performed as described previously
(Fortier and Moineau, 2007).
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